The health economics of attention deficit hyperactivity disorder in Germany. Part 1: Health care utilization and cost of illness;Gesundheitsökonomie der aufmerksamkeitsdefizit-/hyper- aktivitätsstörung in Deutschland: Teil 1: Versorgungsepidemiologie und krankheitskosten

Nervenarzt

Volumn 81, Issue 3, 2010, Pages 289-300

  Schlander, M ^a,b,c   Trott, G E ^a,d   Schwarz, O ^a,e  

^a Institute for Innovation and Valuation in Health Care (InnoValHC)   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Hochschule für Wirtschaft Ludwigshafen am Rhein   (Germany)

^d Hochschule Heilbronn ^*

^e HEILBRONN UNIVERSITY   (Germany)

Author keywords

ADHD; Comorbidity; Cost of illness; Differential diagnosis; Health care utilization

Indexed keywords

ADDICTION; ALCOHOLISM; ATTENTION DEFICIT DISORDER; COST OF ILLNESS; GERMANY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HEALTH INSURANCE; HEALTH PROGRAM; HUMAN; REVIEW; ADOLESCENT; CHILD; ECONOMICS; FEMALE; MALE; PREVALENCE; STATISTICS; UTILIZATION REVIEW;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; FEMALE; GERMANY; HEALTH CARE COSTS; HUMANS; MALE; PREVALENCE; UTILIZATION REVIEW;

EID: 77953269170     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-009-2888-9     Document Type: Review

References (100)

1. Arbeitsgemeinschaft (AG) ADHS der Kinder- und Jugendärzte e.V. (2007) Leitlinie: ADHS (Aufmerksamkeitsdefizits-Hyperaktivitäts- Störung) bei Kindern und Jugendlichen. Aktualisierte Fassung Januar, Forchheim
2. Deutsche Gesellschaft für Kinder- und Jugendpsychiatrie und Psychotherapie (DGKJPP) (Hrsg) (2007) Leitlinien zur Diagnostik und Therapie von psychischen Störungen im Säuglings-, Kindes- und Jugendalter. 3. überarbeitete Aufl. Deutscher Ärzteverlag, Köln
3. Kassenärztliche Bundesvereinigung (KBV) (2008) Qualitä tsgesicherte Versorgung von Kindern und Jugendlichen mit ADHS/ADS. Ein Konzept der Vertragswerkstatt. KBV, Berlin
4. Kassenärztliche Bundesvereinigung (KBV), Kassenärztliche Vereinigung Baden-Württemberg (KVBW) und BKK-Vertragsarbeitsgemeinschaft Baden-Württemberg (2009) Vertrag zur qualitätsgesicherten Versorgung von Kindern und Jugendlichen mit ADHS/ADS (Aufmerksamkeits-Defizit- (Hyperaktivitäts-)Störung) gemäß 73c SGB V. Berlin Stuttgart Kornwestheim
5. Arolt V (2008) Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung: Wachsendes Wissen erfordert neue therapeutische Möglichkeiten. Nervenarzt 79:769-770
6. Retz-Junginer P, Sobanski E, Alm B et al (2008) Alters- und geschlechtsspezifische Besonderheiten der Aufmerksamkeitsdefizit-/ Hyperaktivitätsstörung. Nervenarzt 79:809-819
7. Romanos M, Schwenck C, Walitza S (2008) Diagnostik der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung im Kinder- und Jugendalter. Nervenarzt 79:782-790
8. Weiss G, Hechtman L (1983) Long-term outcome of hyperactive children. Am J Orthopsychiatry 53(3):532-541
9. Barkley RA (1998) Attention-deficit/hyperactivity disorder: a clinical workbook. Guilford Press, New York NY
10. Krause KH, Krause J, Trott GE (1998) Das hyperkinetische Syndrom (Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung) des Erwachsenenalters. Nervenarzt 69:543-556
11. Wender P (2002) Aufmerksamkeitsdefizit-/ Hyperaktivitätsstörungen bei Kindern, Jugendlichen und Erwachsenen. Kohlhammer, Stuttgart
12. Barkley RA, Fischer M, Smallish L, Fletcher K (2006) Young adult outcome of hyperactive Children: Adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry 45(2):192-202
13. Trott GE (2004) Die Aufmerksamkeitsdefizit-/ Hyperaktivitätsstörung im Kindesalter - ein Risikofaktor für die psychische Entwicklung. In: Nissen G (Hrsg) Psychische Störungen im Kindesalter und ihre Prognose. Schattauer, Stuttgart New York
14. World Health Organization (WHO) (1992) International statistical classification of diseases and related health problems (ICD-10). 10. Aufl. World Health Organization, Genf
15. Rappley MD (2005) Attention deficit-hyperactivity disorder. N Engl J Med 352:165-173
16. Costello EJ, Angold A, Burns B et al (1996) The Great Smoky Mountains Study of Youth. Goals, design, methods, and the prevalence of DSM-III-R disorders. Arch Gen Psychiatry 53:1129-1136
17. Baumgärtel A, Wolraich ML, Dietrich M (1995) Comparison of diagnostic criteria for attention deficit disorders in a German elementary school sample. J Am Acad Child Adolesc Psychiatry 34:629-638
18. Faraone SV, Sergeant J, Gillberg C, Biederman J (2003) The worldwide prevalence of ADHD: is it an American condition? World Psychiatry 2(2):104-113
19. Wolraich ML, Hannah JN, Baumgärtel A, Feurer ID (1998) Examination of DSM-IV criteria for attention-deficit/hyperactivity disorder in a county-wide sample. J Dev Behav Pediatr 19(3):162-168
20. Tripp G, Luk SL, Schaughency EA, Singh R (1999) DSM-IV and ICD-10: a comparison of the correlates of ADHD and hyperkinetic disorder. J Am Acad Child Adolesc Psychiatry 38:156-164
21. Brühl B, Döpfner M, Lehmkuhl G (2000) Der Fremdbeurteilungsbogen für hyperkinetische Störungen (FBB-HKS) - Prävalenz hyperkinetischer Störungen im Elternurteil und psychometrische Kriterien. Kindh Entwickl 9:115-125
22. Barbaresi W, Katusic S, Colligan R et al (2004) How common is attention-deficit/hyperactivity disorder? Towards resolution of the controversy. Acta Paediatr [Suppl] 445:55-59
23. Arnold LE (1996) Sex differences in ADHD: conference summary. J Abnorm Child Psychol 24:555-569
24. Biederman J, Kwon A, Aleardi M et al (2005) Absence of gender effects on attention deficit hyperactivity disorder: findings in nonreferred subjects. Am J Psychiatry 162(6):1083-1089
25. Schlack R, Hölling H, Kurth B-M, Huss M (2007) Die Prävalenz der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) bei Kindern und Jugendlichen in Deutschland. Bundesgesundheitsblatt 50(6):827-835
26. Cohen P, Cohen J, Kasen S et al (1993) An epidemiological study of disorders in late childhood and adolescence. I. Age and gender specific prevalence. J Child Psychol Psychiatry 34:851-867 (Pubitemid 23266095)
27. Biederman J, Faraone SV, Spencer T et al (1994) Gender differences in a sample of adults with attention deficit hyperactivity disorder. Psychiatry Res 53:13-29 (Pubitemid 24266118)
28. Krause J, Krause KH (2003) ADHS im Erwachsenenalter. Schattauer, Stuttgart
29. Sobanski E, Alm B (2004) Aufmerksamkeitsdefizit-/ Hyperaktivitätsstörung (ADHS) bei Erwachsenen. Nervenarzt 75:697-715
30. American Psychiatric Association (APA) (1994) Diagnostic and statistical manual of mental disorders (DSM-IV). 4. Aufl. Am Psychiatr Assoc, Washington, DC
31. Koester I, Schubert I, Doepfner M et al (2004) Hyperkinetische Störungen bei Kindern und Jugendlichen: Zur Häufigkeit des Behandlungsanlasses in der ambulanten Versorgung nach den Daten der Versichertenstichprobe der AOK Hessen/KV Hessen (1998-2001). Z Kinder Jugendpsychiatr Psychother 32(3):157-166
32. Schlander M, Schwarz O, Trott GE et al (2007) Who cares for patients with attention-deficit/hyperactivity disorder (ADHD)? Insights from Nordbaden (Germany) on administrative prevalence and physician involvement in health care provision. Eur Child Adolesc Psychiatry 16(7):430-438
33. Schlander M (2007) Aktuelle Daten zur medizinischen Versorgung von Kindern und Jugendlichen mit ADHS in Deutschland: Administrative Prävalenz, beteiligte Arztgruppen und Arzneimitteltherapie. Psychoneuro 33(10):412-415
34. Pastor PN, Reuben CA (2008) Diagnosed attention deficit hyperactivity disorder and learning disability: United States, 2004-2006. National Center for Health Statistics. Vital Health Stat 10 (237)
35. Anonymus (2008) Psychopharmaka für immer mehr Minderjährige - Kassenärztliche Bundesvereinigung: Mediziner wollen gegensteuern - Psychotherapeutische Behandlungen vorrangig. Deutsche Presse-Agentur (dpa)/Main-Echo
36. Zito JM, Safer DJ, de Jong-van den Berg LTW et al (2008) A three-country comparison of pychotropic medication prevalence in youth. Child Adolesc Psychiatry Ment Health 2:26
37. Schlander M (2007) Impact of attention-deficit/hyperactivity disorder (ADHD) on prescription drug spending for children and adolescents: increasing relevance of health economic evidence. Child Adolesc Psychiatry Ment Health 1(13):1-17
38. Stang A (2007) Hyperkinetische Störungen: Ein bundesweiter Vergleich der Hospitalisationsraten. Dtsch Ärztebl 104(19):A1306-A1311 (Pubitemid 47047041)
39. Fayyad J, De Graaf F, Kessler R et al (2007) Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 190:402-409
40. Green M, Wong M, Atkins D et al (1999) Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Technical Review No 3. Agency for Health Care Policy and Research, Rockville, MD, AHCPR Publication No 99-10050
41. Schlander M, Schwarz O, Trott GE et al (2005) Attention-deficit/ hyperactivity disorder (ADHD) in children and adolescents: mental health and physical co-morbidity in Nordbaden/Germany. Value Health 8(6):A196-A197
42. Schlander M, Schwarz O, Trott GE et al (2005) Attention-deficit/ hyperactivity disorder (ADHD) in grown-ups: administrative data on co-existing conditions. Value Health 8(6):A196
43. Hechtman L (2000) Subgroups of adult outcome of attention-deficit/ hyperactivity disorder. In: Brown TE (ed) Attention-deficit disorders and comorbidities in children, adolescents, and adults. Am Psychiatr Press, Washington DC London, pp 437-452
44. Tramontina S, Martins S, Michalowski MB et al (2001) School dropout and conduct disorder in Brazilian elementary school students. Can J Psychiatry 46:941-947
45. Mannuza S, Klein RG, Bessler A et al (1997) Educational and occupational outcome of hyperactive boys grown up. J Am Acad Child Adolesc Psychiatry 36:1222-1227
46. Barkley RA (2002) Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder. J Clin Psychiatry 63 [Suppl 12]:10-15
47. Sobanski E, Brüggemann D, Alm B et al (2008) Subtype differences in adults with attention-deficit/hyperactivity disorder (ADHD) with reagrd to ADHD-symptoms, psychiatric comorbidity and psychosocial adjustment. Eur Psychiatry 23:142-149
48. Anastopoulos AD, Guevremont DC, Shelton TL, DuPaul GJ (1992) Parenting stress among families of children with attention deficit hyperactivity disorder. J Abnorm Child Psychol 20(5):503-520
49. Kaplan BJ, Crawford SG, Fisher GC, Dewey DM (1998) Family dysfunction is more strongly associated with ADHD than with general school problems. J Atten Disord 2(4):209-216
50. Brown RT, Pacini JN (1989) Perceived family functioning, marital status, and depression in parents of boys with attention deficit disorder. J Learn Disabil 22(9):581-587
51. Hankin CS, Wright A, Gephart A (2001) The burden of attention-deficit/ hyperactivity disorder. Drug Benefit Trends 13:7-14
52. Lesesne CA, Visser SN, White CP (2003) Attention-deficit/hyperactivity disorder in school-aged children: association with maternal mental health and use of health care resources. Pediatrics 111:1232-1237
53. Thapar A, Fowler T, Rice F et al (2003) Maternal smoking during pregnancy and attention deficit hyperactivity disorders in offspring. Am J Psychiatry 160(11):1985-1989
54. Langley K, Rice F, van den Bree MB, Thapar A (2005) Maternal smoking during pregnancy as an environmental risk factor for attention deficit hyperactivity disorder behaviour. A review. Minerva Pediatr 57(6):359-371
55. Linnet KM, Dalsgaard S, Obel S et al (2003) Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence. Am J Psychiatry 160(6):1028-1040
56. Garland EJ (1998) Pharmacotherapy of adolescent attention deficit hyperactivity disorder: challenges, choices, and caveats. J Psychopharmacol 12:385-395
57. Woodward LJ, Fergusson DM, Horwood LJ (2000) Driving outcomes of young people with attention difficulties in adolescence. J Am Acad Child Adolesc Psychiatry 39(5):627-634
58. Barkley RA (2004) Driving impairments in teens and adults with attention-deficit/hyperactivity disorder. Psychiatr Clin North Am 27:233-260
59. Skrodzki K (2004) ADHS - Bewegungsstörungen und Unfälle. In: Fitzner T, Stark W (Hrsg) Doch unzerstörbar ist mein Wesen... Diagnose AD(H)S - Schicksal oder Chance? Beltz, Weinheim, S 104-116
60. Sobanski E, Sabljic D, Alm B et al (2008) Driving-related risks and impact of methylphenidate treatment on driving in adults with attention-deficit/hyperactivity disorder. J Neural Transm 115:347-356
61. Murphy KR, Barkley RA (1996) Prevalence of DSM-IV symptoms of ADHD in adult licensed drivers. J Atten Disord 1:147-162
62. Barkley RA, Guevremont DC, Anastopoulos AD et al (1993) Driving-related risks and outcomes of attention deficit hyperactivity disorder in adolescents and young adults: a 3- to 5-year follow-up survey. Pediatrics 92(2):212-218
63. Pastor PN, Reuben CA (2006) Identified attention-deficit/hyperactivity disorder and medically attended, nonfatal injuries: US school-age children, 1997-2002. Ambul Pediatr 6(1):38-44
64. DiScala C, Lescohier I, Barthel M, Li G (1998) Injuries to children with attention deficit hyperactivity disorder. Pediatrics 102(6):1415-1421
65. Mannuza S, Klein RG, Moulton JL III (2002) Young adult outcome of children with " situational" hyperactivity: a prospective, controlled follow-up study. J Abnorm Child Psychol 30:191-198
66. Foley HA, Carlton CO, Howell RJ (1996) The relationship between attention deficit hyperactivity disorder and conduct disorder to juvenile delinquency: legal implications. Bull Am Acad Psychiatry Law 24(3):333-345
67. Rösler M, Retz W, Retz-Junginger P et al (2004) Prevalence of attention deficit-/hyperactivity disorder (ADHD) and comorbid disorders in young male prison inmates. Eur Arch Psychiatry Clin Neurosci 254(6):365-371 (Pubitemid 40192991)
68. Wilens TE, Biederman J, Mick EBA et al (1997) Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance abuse disorders. J Nerv Ment Dis 185(8):475-482
69. Modigh K, Bergren U, Sehlin S (1998) High risk for children with DAMP/ADHD to become addicts later in life. Lakartidningen 95:5316-5319
70. McMahon RJ (1999) Child and adolescent psychopathology as risk factors for subsequent tobacco use. Nicotine Tob Res 1 [Suppl 2]:45-50
71. Tercyak KP, Lerman C, Audrain J (2002) Association of attention-deficit/hyperactivity disorder symptoms with levels of cigarette smoking in a community sample of adolescents. J Am Acad Child Adolesc Psychiatry 41:799-805
72. Wilens TE, Biederman J (2006) Alcohol, drugs, and attention-deficit/ hyperactivity disorder: a model for the study of addictions in youth. J Psychopharmacol 20:580-588
73. Sacco KA, Bannon KL, George TP (2004) Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. J Psychopharmacol 18(4):457-474
74. Bekker EM, Bocker KB, Van Hunsel F et al (2005) Acute effects of nicotine on attention and response inhibition. Pharmacol Biochem Behav 82(3):539-548
75. Pomerleau CS, Downey KK, Snedecor SM et al (2003) Smoking patterns and abstinence effects in smokers with no ADHD, childhood ADHD, and adult ADHD symptomatology. Addict Behav 28(6):1149-1157
76. Rukstalis M, Jepson C, Patterson F, Lerman C (2005) Increases in hyperactive-impulsive symptoms predict relapse among smokers in nicotine replacement therapy. J Subst Abuse Treat 28(4):297-304
77. Humfleet GL, Prochaska JJ, Mengis M et al (2005) Preliminary evidence of the association between the history of childhood attention-deficit/hyperactivity disorder and smoking treatment failure. Nicotine Tob Res 7(3):453-460
78. Barkley RA, Murphy KR, O'Connell T et al (2006) Effects of two doses of alcohol on simulator driving performance in adults with attention-deficit/ hyperactivity disorder. Neuropsychology 20(1):77-87
79. Danckaerts M, Heptinstall E, Chadwick O, Taylor E (1999) Self-report of attention deficit and hyperactivity disorder in adolescents. Psychopathology 32:81-92
80. Knouse LE, Bagwell CL, Barkley RA, Murphy KR (2005) Accuracy of self-evaluation in adults with ADHD: evidence from a driving study. J Atten Disord 8(4):221-234
81. Bernfort L, Nordgeldt S, Persson J (2008) ADHD from a socioeconomic perspective. Acta Paediatr 97:239-245
82. Leibson CL, Long KH (2003) Economic implications of attention-deficit hyperactivity disorder for healthcare systems. Pharmacoeconomics 21(17):1239-1262
83. Schlander M (2004) Vor der Ökonomisierung der ADHS-Therapie? Gesundheitsökonomische Aspekte. In: Fitzner T, Stark W (Hrsg) Doch unzerstörbar ist mein Wesen... Diagnose AD(H)S - Schicksal oder Chance? Beltz, Weinheim, S 417-466
84. Birnbaum HG, Kessler RC, Lowe SW et al (2005) Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000. Curr Med Res Opin 21(2):195-205
85. Matza LS, Paramore C, Prasad M (2005) A review of the economic burden of ADHD. Cost Effectiveness Resource Allocation 3:5
86. Chan E, Zhan C, Homer CJ (2002) Health care use and costs for children with attention-deficit/hyperactivity disorder: national estimates from the medical expenditure panel survey. Arch Pediatr Adolesc Med 156(5):504-511
87. Swensen AR, Birnbaum HG, Secnik K et al (2003) Attention-deficit/ hyperactivity disorder: increased costs for patients and their families. J Am Acad Child Adolesc Psychiatry 42(12):1415-1423
88. Schlander M, Schwarz O, Trott GE et al (2008) Health service expenditures for children and adolescents with and without attention-deficit/hyperactivity disorder (ADHD) in Germany - impact of coexisting conditions. Value Health 11(6):A339
89. Schlander M, Schwarz O, Trott GE et al (2008) Health service expenditures for patients with a diagnosis of attention-deficit/hyperactivity disorder (ADHD) in Germany - an age and gender specific analysis. Value Health 11(6):A588
90. Pelham WE, Foster EM, Robb J (2007) The economic impact of attention-deficit/hyperactivity disorder in children and adolescents. J Pediatr Psychol 52(6):711-727 (Pubitemid 47356048)
91. Wehmeier PM, Schacht A, Rothenberger A (2009) Change in the direct cost of treatment for children and adolescents with hyperkinetic disorder in Germany of four years. Child Adolesc Psychiatry Ment Health 3:3
92. Swensen AR, Birnbaum HG, Ben Hamadi R et al (2004) Incidence and costs of accidents among attention-deficit/hyperactivity disorder patients. J Adolesc Health 35(4):346.e1-346.e9
93. Schwabe U, Paffrath D (Hrsg) (2001) Arzneiverordnungsreport 2000. Aktuelle Daten, Kosten, Trends und Kommentare. Springer, Berlin Heidelberg
94. Schwabe U, Paffrath D (Hrsg) (2006) Arzneiverordnungsreport 2005. Aktuelle Daten, Kosten, Trends und Kommentare. Springer, Berlin Heidelberg
95. Schlander M (2004) Budgetary impact of treatments for attention-deficit/hyperactivity disorder (ADHD) in Germany: increasing relevance of health economic evidence. 16th World Congress of the International Association for Child and Adolescent Psychiatry and Allied Professions (IACAPAP), Berlin, 22.-26. August 2004. Book of Abstracts, S 111-516. Steinkopff, Darmstadt, S 187
96. Noe L, Hankin CS (2001) Health outcomes of childhood attention-deficit/ hyperactivity disorder (ADHD): health care use and work status of caregivers. Value Health 4(2):140-141
97. Kessler RC, Lane M, Stang PE, Van Brunt DL (2008) The prevalence and workplace costs of adult attention deficit hyperactivity disorder in a large manufacturing firm. Psychol Med 21:1-11 (epub ahead of print)
98. De Graaf R, Kessler RC, Fayyad J et al (2008) The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative. Occup Environ Med May 2007 (epub ahead of print)
99. Biederman J, Faraone SV (2005) Economic impact of adult ADHD. Program and abstracts of the American Psychiatric Association (APA) 2005 Annual Meeting: Atlanta, GA, May 21-26, 2005. Poster 289
100. Schlander M, Trott GE, Schwarz O (2009) Gesundheitsökonomie der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung - Teil 2: Therapeutische Optionen und ihre Kosteneffektivität. Nervenarzt (im Druck)